Babao Dan with antiviral therapy for hepatitis B cirrhosis
Part of Cancer, Digestive system, Infections clinical trials.
This study tests whether an herbal capsule (Babao Dan) combined with standard antiviral therapy can help prevent liver cancer in people with cirrhosis caused by hepatitis B. It aims to see if adding this traditional Chinese medicine reduces the chance of developing liver cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with cirrhosis caused by hepatitis B.
- You must not have had liver cancer or any other cancer before.
- You cannot have severe liver complications like fluid in the belly, confusion, or bleeding.
- You must not have other liver conditions like hepatitis C, HIV, alcohol-related liver disease, or drug-induced liver injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether adding a Chinese herbal medicine called Fufang Biejiaruangan to standard antiviral therapy can lower the chance of developing liver cancer in people with hepatitis B-related cirrhosis. If you are at higher risk for liver cancer, this combination might help prevent it.
This study tests whether a Chinese herbal medicine called Biejia-Ruangan Compound can help people with early-stage liver cancer who have already had successful treatment (surgery or ablation) live longer and keep the cancer from coming back. It is for people who also have chronic hepatitis B.
This study looks at whether giving antiviral medicine after liver cancer treatment helps prevent the cancer from coming back and improves overall outcomes. It is for people with hepatitis B who have had their liver cancer removed or destroyed with a procedure.
This study looks at how to best use existing hepatitis B “nucleotide-analog” tablets in everyday care. It may help tailor when to start, and whether to continue or adjust treatment, based on your test results.
This study tests whether taking vitamin D by mouth can help prevent liver cancer in people with chronic hepatitis B who are already on antiviral medication. If you have hepatitis B and are being treated at the Third Affiliated Hospital of Sun Yat-sen University, you may be able to join.
This trial tests whether a Chinese herbal medicine called Fuzheng Huayu can help prevent another serious liver complication after your first one. It is for people with hepatitis B-related cirrhosis who have recently had a complication like fluid in the belly or bleeding.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.